Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 743

1.

Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV).

Senga M, Arabi YM, Fowler RA.

J Infect Public Health. 2016 Apr 29. pii: S1876-0341(16)30025-9. doi: 10.1016/j.jiph.2016.04.008. [Epub ahead of print] No abstract available.

PMID:
27140697
2.

ANTIDYSRHYTHMIC AGENTS. Managing prehospital stable v tach.

Cortez E, Cash C, Keseg DP, Fowler RL.

JEMS. 2016 Mar;41(3):48-51. No abstract available.

PMID:
27120857
3.

The search for therapeutic options for Middle East Respiratory Syndrome (MERS).

Arabi YM, Balkhy HH, Hayden FG, Hui DS, Van Kerkhove MD, Fowler RA.

J Infect Public Health. 2016 Mar 31. pii: S1876-0341(16)30016-8. doi: 10.1016/j.jiph.2016.03.004. [Epub ahead of print] No abstract available.

PMID:
27050470
4.

Long-term outcomes and healthcare utilization following critical illness - a population-based study.

Hill AD, Fowler RA, Pinto R, Herridge MS, Cuthbertson BH, Scales DC.

Crit Care. 2016 Mar 31;20(1):76. doi: 10.1186/s13054-016-1248-y.

5.

The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.

Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, Marshall JC, Cook DJ, Jouvet P, Ferguson ND, Griesdale D, Burry LD, Burns KE, Hutchison J, Mehta S, Menon K, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative.

Crit Care. 2016 Mar 30;20(1):75. doi: 10.1186/s13054-016-1230-8.

6.

Proceedings of the Middle East Respiratory Syndrome (MERS) Coronavirus research initiative workshop, September 9-10 2015 in Riyadh, KSA.

Arabi YM, Fowler R, Balkhy HH.

J Infect Public Health. 2016 Mar 29. pii: S1876-0341(16)30017-X. doi: 10.1016/j.jiph.2016.03.005. [Epub ahead of print] No abstract available.

PMID:
27036308
7.

The RECOVER Program: Disability Risk Groups & One Year Outcome after ≥ 7 Days of Mechanical Ventilation.

Herridge MS, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, Friedrich JO, Mehta S, Lamontagne F, Levasseur M, Ferguson ND, Adhikari NK, Rudkowski JC, Meggison H, Skrobik Y, Flannery J, Bayley M, Batt J, Dos Santos C, Abbey SE, Tan A, Lo V, Mathur S, Parotto M, Morris D, Flockhart L, Fan E, Lee CM, Wilcox ME, Ayas N, Choong K, Fowler R, Scales DC, Sinuff T, Cuthbertson BH, Rose L, Robles P, Burns S, Cypel M, Singer L, Chaparro C, Chow CW, Keshavjee S, Brochard L, Hebert P, Slutsky AS, Marshall JC, Cook D, Cameron JI; RECOVER Program Investigators (Phase 1: towards RECOVER) and the Canadian Critical Care Trials Group..

Am J Respir Crit Care Med. 2016 Mar 14. [Epub ahead of print]

PMID:
26974173
8.

Effectiveness of trigger point dry needling for multiple body regions: a systematic review.

Boyles R, Fowler R, Ramsey D, Burrows E.

J Man Manip Ther. 2015 Dec;23(5):276-93. doi: 10.1179/2042618615Y.0000000014.

PMID:
26955257
9.

Risk factors for and prediction of mortality in critically ill medical-surgical patients receiving heparin thromboprophylaxis.

Li G, Thabane L, Cook DJ, Lopes RD, Marshall JC, Guyatt G, Holbrook A, Akhtar-Danesh N, Fowler RA, Adhikari NK, Taylor R, Arabi YM, Chittock D, Dodek P, Freitag AP, Walter SD, Heels-Ansdell D, Levine MA.

Ann Intensive Care. 2016 Dec;6(1):18. doi: 10.1186/s13613-016-0116-x. Epub 2016 Feb 27.

10.

Knowledge gaps in therapeutic and non-therapeutic research on the Middle East respiratory syndrome.

Arabi YM, Fowler R, Bright RA, Van Kerkhove MD, Balkhy HH.

Lancet Respir Med. 2016 Feb;4(2):93-4. doi: 10.1016/S2213-2600(16)00007-2. No abstract available.

PMID:
26868624
11.

Evaluation of Persistent Organ Dysfunction Plus Death As a Novel Composite Outcome in Cardiac Surgical Patients.

Stoppe C, McDonald B, Benstoem C, Elke G, Meybohm P, Whitlock R, Fremes S, Fowler R, Lamarche Y, Jiang X, Day AG, Heyland DK.

J Cardiothorac Vasc Anesth. 2016 Jan;30(1):30-8. doi: 10.1053/j.jvca.2015.07.035. Epub 2015 Jul 29.

PMID:
26847748
12.

The determinants of home and nursing home death: a systematic review and meta-analysis.

Costa V, Earle CC, Esplen MJ, Fowler R, Goldman R, Grossman D, Levin L, Manuel DG, Sharkey S, Tanuseputro P, You JJ.

BMC Palliat Care. 2016 Jan 20;15:8. doi: 10.1186/s12904-016-0077-8.

13.

Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.

Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ; International Consortium for End-of-Life Research (ICELR).

JAMA. 2016 Jan 19;315(3):272-83. doi: 10.1001/jama.2015.18603.

PMID:
26784775
14.

Association Between Hospitalization for Heart Failure and Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes: An Observational Study.

Fu AZ, Johnston SS, Ghannam A, Tsai K, Cappell K, Fowler R, Riehle E, Cole AL, Kalsekar I, Sheehan J.

Diabetes Care. 2016 Jan 6. pii: dc150764. [Epub ahead of print]

PMID:
26740636
15.

Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.

Mattia JG, Vandy MJ, Chang JC, Platt DE, Dierberg K, Bausch DG, Brooks T, Conteh S, Crozier I, Fowler RA, Kamara AP, Kang C, Mahadevan S, Mansaray Y, Marcell L, McKay G, O'Dempsey T, Parris V, Pinto R, Rangel A, Salam AP, Shantha J, Wolfman V, Yeh S, Chan AK, Mishra S.

Lancet Infect Dis. 2016 Mar;16(3):331-8. doi: 10.1016/S1473-3099(15)00489-2. Epub 2015 Dec 23.

PMID:
26725449
16.

The case for routine goals-of-care documentation.

Yarnell C, Fowler R.

BMJ Qual Saf. 2015 Dec 15. pii: bmjqs-2015-004776. doi: 10.1136/bmjqs-2015-004776. [Epub ahead of print] No abstract available.

PMID:
26669932
17.

The BVM Effect. An overview of studies assessing airway management in out-of-hospital cardiac arrest.

Fowler RL, Leba C, Mehkri F, Idris AH.

JEMS. 2015 Oct;40(10):58-61, 67.

PMID:
26669069
18.

Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study.

Faye O, Andronico A, Faye O, Salje H, Boëlle PY, Magassouba N, Bah EI, Koivogui L, Diallo B, Diallo AA, Keita S, Konde MK, Fowler R, Fall G, Cauchemez S, Sall AA.

PLoS Med. 2015 Dec 1;12(12):e1001908. doi: 10.1371/journal.pmed.1001908. eCollection 2015 Dec.

19.

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol.

Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R.

Springerplus. 2015 Nov 19;4:709. doi: 10.1186/s40064-015-1490-9. eCollection 2015.

20.

Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli.

Geyer CN, Fowler RC, Johnson JR, Johnston B, Weissman SJ, Hawkey P, Hanson ND.

J Antimicrob Chemother. 2016 Mar;71(3):607-16. doi: 10.1093/jac/dkv388. Epub 2015 Nov 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk